Timothy K. Lu
CEO, Director · Senti Biosciences, Inc.
Individual
- 2026
- Mar 11, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Timothy K. Lu. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BAYER HEALTHCARE LLC - SNTI
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Timothy K. Lu?
Timothy K. Lu is a corporate insider, tracked as CEO, Director of Senti Biosciences, Inc. (SNTI). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Timothy K. Lu last file a Form 4?
The most recent primary Form 4 on record is dated 11 March 2026, one of 2 filings going back to 2026.
